Long-Time Smoker With Cancer Awarded $20.7 Million in Case Against Tobacco Firms – Go Health Pro

Long-Time Smoker With Cancer Awarded .7 Million in Case Against Tobacco Firms – Go Health Pro

A 72-year old man who smoked cigarettes for 55 years starting when he was 10-years old and suffered two bouts of cancer has won a $20.7 million verdict in a case against tobacco companies. A jury in Massachusetts Superior Court for Middlesex County found that cigarettes made by R.J. Reynolds and Santa Fe Natural Tobacco … Read more

Breast Cancer Survivor Encourages Early Testing – Go Health Pro

Breast Cancer Survivor Encourages Early Testing – Go Health Pro

Champion and her sister each had to undergo chemotherapy due to the aggressiveness of the breast cancer. Fortunately, neither needed radiation treatment. “As much as no one wants to be diagnosed, it was a gift,” said Champion, reflecting on going through treatment with her sister. “We did it side by side. We encouraged and supported … Read more

Germany’s BioNTech buys China’s Biotheus in US$800 million push into cancer drugs – Go Health Pro

Germany’s BioNTech buys China’s Biotheus in US0 million push into cancer drugs – Go Health Pro

BioNTech, the German developer of a widely used mRNA vaccine for the coronavirus, agreed to pay US$800 million (HK$6.24 billion) to buy biotech company Biotheus, a developer of cancer drugs. In a statement on Wednesday, Mainz-based BioNTech said it signed a definitive agreement to pay mostly cash for 100 per cent of Biotheus, which is … Read more

Zacks Small Cap Analysis – VNRX: Nu.Q Vet Check is now obtainable in 17 international locations. Value slicing continues in a plan to be money move impartial in 2025. Administration centered on signing licensing offers for Seize-PCR (human most cancers detection technique) and Nu.Q NET for sepsis. $7.0 million financing accomplished. – Go Well being Professional

Zacks Small Cap Analysis – VNRX: Nu.Q Vet Check is now obtainable in 17 international locations. Value slicing continues in a plan to be money move impartial in 2025. Administration centered on signing licensing offers for Seize-PCR (human most cancers detection technique) and Nu.Q NET for sepsis. .0 million financing accomplished. – Go Well being Professional

By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT SIGNIFICANT OPERATIONAL UPDATES Administration is implementing a important value slicing program with the aim of making certain that Volition (NYSE:VNRX) is money move impartial in 2025. Value reductions taken throughout 1H 2024 resulted in a 15.9% decline in working bills. Value discount measures have … Read more

x